Home / Europe / Serbia / Public Procurement

Public Procurement Law Firm in Serbia

Contracting authorities and bidders in local, EU and international procurement procedures, need to rely on legal advice informed by extensive experience on both sides of the process. Public procurement legislation has undergone some significant changes in Central and Eastern Europe in recent years. Despite legislation moving closer towards harmonisation with the EU, many practical challenges remain.

CMS has worked on scores of complex projects in the region over the last two decades and fields specialist public procurement lawyers across 15 full-service offices. Our lawyers offer a powerful combination of local expertise and insight coupled with international know-how and perspective on public procurement issues. We can guide you through complex public tender issues, from the formation and building of bidding consortia, concession contracts and sophisticated PPP projects, through to compliance, investigations and procurement-related disputes and litigation.

In the CEE/SEE region and across CMS, our specialists have longstanding sector-expertise across core industries including infrastructure, lifesciences/healthcare, transport, and technology, media and communications. This approach means we can resolve your complex public tender issues, including formation and building of bidding consortia, protection of confidential information, anti-trust matters, evaluations, specific rules around framework agreements, concession contracts and complex PPP projects. Further, we can assist regarding feedback and debriefing and how to approach different regulated tender procedures. We also provide support before tribunals and courts across Europe or in front of the European Commission.

Choose area

yellow pencil on yellow paper
Regulatory
Regulatory provisions are constantly on the rise in numerous sectors and particularly internationally active companies have to deal with a growing num

Feed

08/11/2023
CMS Life Sciences Vital Signs, Winter 2023
2023 has seen some significant legal developments impacting the life sciences industry, and as we look ahead to 2024, there are several important developments which we would like to keep our clients informed...
28/03/2023
European Parliament and Council ready to start negotiations on EU Data...
In February 2022 the European Commission presented its proposal for the EU Data Act, which – if adopted - will introduce a far-reaching legal regime on access to and use of non-personal data in the...
20/02/2023
Sunrise period of the Unified Patent Court to begin 1 March
After the final version of the UPC Rules of Procedure had been adopted and the judges of the UPC had been selected and appointed, the start of the Sunrise Period, originally planned for 1 January 2023...
13/09/2022
UPC Rules of Procedure go into force with judgments to be made public
The entry into force of the Rules of Procedure is part of the final preparations for the United Patent Court (UPC), which is currently expected to start work in early 2023. After the bodies of the UPC...
26/08/2022
Public procurement regulation in Serbia
The Law on Public Procurements specifies that a contracting authority need not apply that law for the procurement of goods, services or works whose annual value is less than RSD 500,000 (approx. EUR 4,200)...
24/06/2022
Regulation on foreign subsidies is heading for the finish line - European...
Since 5 May 2022, EU trilogue negotiations have been underway on the first Regulation to limit the effect of subsidies from third countries to companies active in the EU. That an agreement will be reached...
27/02/2022
Handling the new EU and UK sanctions against Russia
Since 2014, the EU and the UK have progressively imposed sanctions on Russia in response to the crisis in Ukraine. Following the latest events, both the EU and the UK, as well as many other countries...
24/11/2021
On the Pulse
A video/podcast series, On the Pulse, brings together CMS lawyers and experts to discuss key industry topics impacting, innovating and disrupting the life sciences & healthcare sector.  The series is hosted by  , Global Co-Head of CMS Life Sciences & Healthcare Sector Group. Subscribe, download, watch and listen to the CMS ‘On the Pulse’ videos  and podcasts . Array
30/08/2021
Serbia: Confidentiality in Managed Entry Agreements Under Serbian Law
Array Managed Entry Agreements consist of various forms of confidential arrangements between pharmaceutical companies and paying healthcare systems that aim to facilitate access to new technologies in public healthcare systems. MEAs make innovative and costly medicines or medical technologies affordable to patients by providing conditional access to a reimbursement system for a limited period and on balanced terms.
23/03/2021
CMS On the Pulse episode #8: A legal overview on public procurement for...
The Global Life Sciences & Healthcare Sector Group is delighted to release the latest episode in its video/podcast series, On the Pulse. The series brings together CMS lawyers and experts to discuss key...
09/02/2021
BAT conclusions for large combustion plants annulled – What next?
On 27 January 2021 the General Court of the European Union declared the so-called BAT conclusions for large combustion plants annulled. It is worth considering what this ruling really means and what it...
15/12/2020
Five years after Huawei ZTE FRAND licensing obligations again before the...
On 26 November 2020, the Düsseldorf Regional Court announced that it would suspend a patent infringement proceeding and refer key questions on compulsory licensing of standard essential patents (SEP)...